Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Amortization - GoodwillCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares Issued
Ratios

Legend Biotech (LEGN) Gross Profit (2019 - 2025)

Legend Biotech filings provide 7 years of Gross Profit readings, the most recent being $242.1 million for Q4 2025.

  • On a quarterly basis, Gross Profit rose 75.94% to $242.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $822.9 million, a 71.52% increase, with the full-year FY2025 number at $823.1 million, up 71.55% from a year prior.
  • Gross Profit hit $242.1 million in Q4 2025 for Legend Biotech, up from $219.7 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $45.8 billion in Q4 2023 to a low of -$13.4 billion in Q1 2021.
  • Median Gross Profit over the past 5 years was $60.8 million (2023), compared with a mean of $1.7 billion.
  • Biggest five-year swings in Gross Profit: plummeted 268112.76% in 2021 and later skyrocketed 2529568.51% in 2023.
  • Legend Biotech's Gross Profit stood at -$13.8 million in 2021, then surged by 113.1% to $1.8 million in 2022, then skyrocketed by 2529568.51% to $45.8 billion in 2023, then crashed by 99.7% to $137.6 million in 2024, then soared by 75.94% to $242.1 million in 2025.
  • The last three reported values for Gross Profit were $242.1 million (Q4 2025), $219.7 million (Q3 2025), and $207.0 million (Q2 2025) per Business Quant data.